High levels of Gal-3 expression in HNSCC were associated with increased progression, invasiveness, and aggressiveness in part by the activation of pathways such as the Wnt/B-catenin, ERK1/2, and AKT pathways. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.